Skip to main content
Clinical Kidney Journal logoLink to Clinical Kidney Journal
. 2018 Jan 4;11(4):443–449. doi: 10.1093/ckj/sfx144

Acute kidney injury among adult patients undergoing major surgery in a tertiary hospital in Nigeria

Yemi Raheem Raji 1,, Samuel Oluwole Ajayi 1, Adeyinka F Ademola 2, Taiwo Akeem Lawal 2, Omobolaji O Ayandipo 2, Tinuola Adigun 3, Babatunde Salako 1
PMCID: PMC6070100  PMID: 30094006

Abstract

Background

Acute kidney injury (AKI) is an underreported but major cause of morbidity and mortality among patients undergoing major surgical interventions in sub-Saharan Africa (SSA). Whereas AKI is often seen following major cardiac surgery in high-income countries, a similar spectrum of surgical diseases and interventions is not seen in developing countries. The impacts on surgical outcomes have also not been well characterized in SSA. This study aimed at identifying risk factors, incidence and determinants and short-term outcomes of AKI among patients undergoing major surgery.

Methods

This was a cohort study of adult patients undergoing major surgery at the University College Hospital, Ibadan, Nigeria. Data obtained were sociodemographic details, risk factors for AKI, details of surgery, anaesthesia and intra-operative events and short-term outcomes. Blood samples were obtained for pre-operative (pre-op) full blood count, serum electrolytes, blood urea and creatinine (SCr). Post-operatively (Post-op) SCr was determined at 24 h, Day 7 post-op and weekly until each patient was discharged.

Results

A total of 219 subjects who had major surgery (86.3% elective) were enrolled. The median age of the patients was 46 (range 18–73) years and 72.6% were females. The surgeries performed were mostly simple mastectomies (37.4%), exploratory laparotomies (22.8%) and total thyroidectomies (16.4%). The incidences of AKI were 18.7% at 24 h and 17.4% at Day 7 post-op, while cumulative AKI incidence was 22.5% at 1-week post-op. Pre-op elevated SCr [odds ratio (OR) 3.86], sepsis (OR 2.69), anaemia (OR 2.91) and duration of surgery >120 min (OR 1.75) were independently associated with AKI. In-patient mortality was 20.4% in individuals with AKI and 5.3% in those without AKI (P < 0.01).

Conclusion

Peri-operative risk factors for AKI are common among patients undergoing major surgery in SSA hospitals. The cumulative incidence of AKI was high and independently associated with pre-op sepsis, anaemia, pre-existing kidney dysfunction and duration of surgery >120 min.

Keywords: acute kidney injury (AKI), incidence, risk factors, sub-Saharan Africa, surgery

Background

Acute kidney injury (AKI) is a major cause of morbidity and mortality among patients undergoing major surgical interventions worldwide and contributes to prolonged hospital stays and increased cost of treatments [1, 2]. The epidemiology of AKI appears different between high-income countries (HICs) and low- and middle-income countries (LMICs) [3, 4]. Whereas it is often seen following major cardiac surgery in the former, this is not the case in LMICs [4–6].

A review by Adu et al. [7] estimated the incidence of AKI among hospitalized patients in the sub-Saharan Africa (SSA) region to be 1.9%. In contrast, a recent study by Evans et al. [8] reported the incidence of AKI among 892 cases of medical admissions in a Malawian hospital to be 17.2%, with an in-hospital mortality rate of 44.4%. The outcome of AKI in the SSA region is poor compared with HICs. Olowu et al. [9] reported that only 64% of 1042 children and 33% of 178 adults with AKI across many studies received dialysis when needed. While the overall mortality was 34% in children and 32% in adults, the mortality rose to 73% in children and 86% in adults when dialysis was needed but not received [9]. Most of the reports from the SSA region are on community-acquired AKI, while reports on the epidemiology of AKI among individuals undergoing surgery are sparse. With the increase in volume of surgical procedures performed in SSA [10], it has been hypothesized that most cases of surgery-related [peri-operative (peri-op)] AKI are underdetected. The impact of delayed or undetected AKI is enormous in patients undergoing surgical interventions and it is associated with increased morbidity and mortality, prolonged hospital stay and higher cost of treatment [11, 12].

Despite peri-op AKI being a preventable disease with enormous benefits of early detection and intervention, which is feasible through identification of risk factors and prompt institution of appropriate treatment during the peri-op period, very limited data are available on the incidence of AKI and its risk factors among patients undergoing surgery in the SSA region. The primary objective of this study was to identify peri-op risk factors and determine the pattern of AKI among patients undergoing major surgery in a leading tertiary hospital in Nigeria and the secondary objective was to determine the short-term outcomes of AKI among the participants.

Materials and methods

Study design and participants

This was a short-term follow-up study of 219 adult patients undergoing major surgical interventions at the University College Hospital, Ibadan, Nigeria. Consecutively presenting patients requiring elective or emergency surgery were enrolled in the study between 1 October 2015 and 31 January 2016. Inclusion criteria were individuals 18–74 years of age while exclusion criteria were individuals with <18 or >74 years of age, primarily obstructive urological disease, end-stage renal disease (ESRD) or on renal replacement therapy (RRT). Standard case report forms were used to collect data from the participants. Data obtained included sociodemographic details, risk factors for AKI [pre-operative (pre-op) sepsis, diabetes mellitus, pre-existing kidney disease, presence of comorbidity, anaemia, emergency surgery, prolonged duration of anaesthesia, prolonged duration of surgery, intra-op blood loss, intra-operative (intra-op) hypotension, intra-op hypertension, post-operative (post-op) sepsis, post-op fluid loss through the surgical drain, use of multiple antibiotics and analgesics], lifestyle, medical histories, clinical diagnosis, types and duration of surgery, episodes of hypotension and details of anaesthesia. Pre-, intra- and post-op serum electrolytes, urea and creatinine and full blood count were carried out while noting the vital signs, intra-op blood loss, fluid input and output, use of inotropic agents and the need for blood transfusion. Post-op blood samples were also collected for serum creatinine (SCr) within 24 h of surgery, Day 7 post-op and weekly until participants were discharged home.

AKI was defined and graded in accordance with the Kidney Disease: Improving Global Outcomes (KDIGO) 2012 criteria (Table 1), while pre-existing kidney dysfunction, anaemia, sepsis, hypertension, intra-op hypertension and hypotension, diabetes mellitus, prolonged and major surgery and recovery of kidney function are defined as shown in Table 1.

Table 1.

Definitions of diagnostic criteria

Variable Definition
AKI Increase in serum creatinine by ≥ 0.3 mg/dL (≥26.5 µmol/L) within 48 h OR increase in SCr to >1.5 times baseline that is known or presumed to have occurred within the prior 7 days OR urine volume <0.5 mL/kg/h for 6 h [13]
Pre-existing kidney dysfunction eGFR <60 mL/min/1.73 m2 [14]
Anaemia Haemoglobin <11 g/dL [15]
Sepsis The presence of confirmed (culture) or presumed identifiable microbes with two or more features of SIRS. Features of SIRS include fever (temperature >38 °C) or hypothermia (temperature <36 °C), tachycardia (pulse rate >90/min), tachypnoea (respiratory rate >20/min) and leucocytosis (WBC >11 × 106/mm3) or leucopenia (WBC <4 × 106/mm3) [16, 17]
Hypertension SBP ≥140 mmHg or diastolic DBP ≥90 mmHg, presence of hypertension previously diagnosed by a physician or use of antihypertensive medications to control BP [18]
Diabetes mellitus Fasting plasma glucose >7 mmol/L, diabetes mellitus diagnosed previously by a physician or use of antidiabetic medications to control blood sugar [19]
Intra-operative hypotension Increase in mean arterial BP > 20% from the baseline, lasting 5–10 min. Intra-op hypotension was defined as absolute SBP <80 mmHg or a drop in the baseline SBP of >20% lasting at least 5–10 min [20, 21]
Major surgery Any surgical procedure that required at least a regional or general anaesthesia, surgery that lasts >120 min in duration or surgery requiring in-hospital care
Full recovery of kidney function SCr return to baseline value or below [22]
Partial recovery of kidney function Change from higher AKI severity stage to a lower one but not below Stage I or a reduction in SCr of > 25% from the highest value attained [22]
Prolonged surgery Surgical interventions lasting >120 min [23]
KDIGO staging of AKI
 Stage I Increased SCr 1.5–1.9 times from the baseline OR urine output <0.5 mL/kg/h for 6–12 h
 Stage II Increased SCr 2.0–2.9 times from baseline OR urine output <0.5 mL/kg/h for ≥12 h
 Stage III Increased absolute SCr to > 4.0 mg/dL (>353.6 mmol/L) OR initiation of RRT OR increased SCr 3.0 times from baseline OR 0.3 mL/kg/h for ≥24 h OR anuria for ≥12 h [13]

SIRS, systemic inflammatory response syndrome; WBC, white blood cell count.

Statistical analysis

Statistical analyses were done using the Statistical Package for Social Sciences (SPSS) version 20 (IBM, Armonk, NY, USA). Continuous variables are expressed as means or medians and categorical variables are expressed as proportions. Paired t-test was used to test for association between continuous variables that were normally distributed and continuous variables that were not normally distributed were compared using the Mann–Whitney U-test. Associations between categorical variables were compared using the chi-square test or Fisher’s exact test as appropriate. Linear and multiple logistic regression analyses were conducted to identify factors that were independently associated with the development of AKI. Associations between variables were considered to be significant for P-values <0.05.

Ethical approval

This study adhered to the Declaration of Helsinki and ethical approval was obtained from the Joint University of Ibadan and University College Hospital, Ibadan Institutional Review Board. All participants gave written informed consent.

Results

Clinical characteristics of the participants

A total of 219 participants who had major surgery were recruited into the study; the median age of the patients was 46 (range 18–73) years and 159 (72.6%) were females. The median duration of surgery was 100 (range 30–433) min and the median pre-op systolic blood pressure (SBP) and diastolic blood pressure (DBP) was 120 (range 70–190) mmHg and 80 (range 50–150) mmHg, respectively. A total of 189 (86.3%) participants underwent elective surgery while 30 (13.7%) had emergency surgical interventions. The medians were significantly higher among the participants with AKI compared with those without AKI for the duration of surgery and pre-op, 24-h and 1-week post-op SCr, while the median estimated glomerular filtration rate (eGFR) was significantly lower in the participants with AKI compared with those without AKI (Table 2). In addition, AKI at the end of 1 week was significantly associated with gender. The spectrums of surgical diseases among the participants were predominantly breast carcinoma, simple multinodular goitre, abdominal ventral hernia and acute appendicitis (Table 2). The surgical interventions carried out were mainly simple mastectomies, exploratory laparotomies, total thyroidectomies, appendectomies and wide excision of soft tissue sarcomas and the proportions were similar in participants with and without AKI (Table 2). General anaesthesia was administered to 198 (90.4%) patients while spinal anaesthesia was the choice in the remaining [21 (9.6%)] participants (Table 2).

Table 2.

Baseline characteristics of patients who underwent major surgical interventions

Variables Peri-op AKI (n = 49) No peri-op AKI (n = 170) P-value
Gender, n (%)
 Female 29 (59.2) 129 (76.3) 0.02*
 Male 20 (40.8) 41 (23.7)
Age (years), median (range) 49 (19–73) 46 (18–74) 0.23
SBP (mmHg), median (range) 120 (70–180) 120 (80–190) 0.96
DBP (mmHg), median (range) 80 (52–150) 80 (50–115) 0.75
Duration of primary surgical illness (months), median (range) 6 (1–96) 10.5 (1–205) 0.12
Duration of surgery (min), median (range) 105 (45–433) 96 (30–350) 0.03*
Pre-op SCr (µmol/L), median (range) 106 (44.5–371.3) 79.6 (61.7–97.2) 0.01*
24-h post-op SCr (µmol/L), median (range) 106 (30.4–344.8) 88.4 (23.2–132.5) 0.01*
Day 7 post-op SCr (µmol/L), median (range) 105 (32.0–319.5) 92 (34.6–138.3) 0.01*
eGFR (mL/min/1.73 m2), median (range) 77 (39.7–160.4) 96 (73.4 ±153.0) 0.01*
Haemoglobin (g/dL), mean ± SD 7.4±1.6 7.2±1.4 0.86
Types of surgery, n (%)
 Emergency 14 (28.6) 16 (9.4) 0.01*
 Elective 35 (71.4) 154 (90.6)
Presence of at least one comorbidity, n (%) 15 (30.6) 56 (32.9) 0.76
Surgical diagnoses, n (%)
 Breast carcinoma 17 (34.5) 63 (37.1) 0.86
 Thyroid tumour 10 (20.4) 26 (15.2)
 Abdominal wall hernia 4 (8.9) 10 (5.8)
 Acute appendicitis 3 (6.1) 11 (64.7)
 Intestinal obstruction 3 (6.1) 7 (4.1)
 Pancreatic carcinoma 2 (4.1) 7 (4.1)
 Soft tissue sarcoma 0 (0) 8 (4.7)
 Colorectal carcinoma 1 (2.0) 5 (2.9)
 Enterocutaneous fistula 1 (2.0) 4 (2.4)
 Others 8 (16.3) 29 (17.1)
Surgical interventions, n (%)
 Mastectomy 21 (42.9) 59 (34.7) 0.38
 Exploratory laparotomya 13 (26.5) 40 (23.5)
 Thyroidectomy 2 (4.1) 34 (20.0)
 Appendectomy 5 (10.2) 6 (3.5)
 Wide excision (sarcoma) 1 (2.0) 10 (5.9)
 Herniorrhaphy 1 (2.0) 9 (5.3)
 Axillary clearance 2 (4.1) 1 (0.6)
 Cholecystectomy 1 (2.0) 2 (1.2)
 Others 3 (6.1) 11 (1.8)
Types of anaesthesia used, n (%)
 GA with isoflurane plus propofol 36 (73.4) 134 (78.8) 0.43
 GA with halothane 7 (14.3) 20 (11.8)
 GA with ketamine 1 (2.0) 3 (1.8)
 Spinal anaesthesia 5 (10.3) 13 (7.6)

BP, blood pressure; GA, general anaesthesia; SD, standard deviation.

*P-value less than 0.05.

aExploratory laparotomy in 30 cases (13.7%) were with additional surgical procedures such as bowel resection, appendectomy, splenectomy or adhesiolysis.

Peri-op risk factors

Pre-op sepsis, pre-op anaemia, pre-existing kidney dysfunction and emergency cases were observed to be significantly higher among participants with AKI on bivariate analysis, while diabetes mellitus and hypertension were not associated with AKI (Table 3). Pre-op sepsis was significantly higher among participants who had emergency surgery [8 (26.7%)] compared with elective cases [17 (8.9%); P < 0.01]. A duration of surgery >120 min, a duration of anaesthesia >120 min and the need for intra-op blood transfusion were the identified intra-op AKI risk factors that were significantly higher among the individuals with AKI (Table 3), while the post-op risk factors for AKI were similar in individuals with AKI and those without AKI (Table 3).

Table 3.

Peri-op characteristics of participants with AKI and those without AKI

Risk factors Peri-op AKI (n = 49) No peri-op AKI (n = 170) P-value
Pre-op risk factors, n (%)
 Age >60 years 8 (16.3) 20 (11.8) 0.69
 Pre-op sepsis 12 (28.6) 12 (7.1) 0.01*
 Presence of at least one co-morbidity 16 (32.6) 56 (32.9) 0.76
 Elevated pre-op BP 16 (32.5) 62 (36.5) 0.60
 Hypertension 9 (18.4) 40 (23.5) 0.48
 Diabetes mellitus 4 (8.1) 10 (5.9) 0.56
 Proteinuria 11 (22.5) 20 (11.8) 0.06
 Pre-op anaemia 22 (44.9) 40 (23.5) 0.01*
 Pre-op leucocytosis 7 (14.2) 12 (7.1) 0.09
 Pre-existing kidney dysfunction 13 (26.6) 6 (3.5) 0.02*
Intra-op risk factors ±
 Prolonged duration of surgery >120 min 32 (65.3) 29 (17.1) 0.01*
 Prolonged duration of anaesthesia >120 min 33 (67.3) 40 (23.5) 0.01*
 Intra-op hypotension 4 (4.1) 9 (5.3) 0.23
 Intra-op hypertension 2 (2.1) 6 (3.5)
 EBL >500 mL 15 (30.6) 31 (18.2) 0.09
 Intra-op blood transfusion 28 (57.1) 34 (20.0) 0.02*
 Need for >3 L intra-op 12 (24.5) 23 (13.5) 0.07
 Need for inotropic support 1 (2.0) 2 (1.2) 0.65
Post-op risk factors ±
 Drain >500 mL/day 10 (20.4) 28 (16.5) 0.52
 Had 2 or more post-op antibiotics 11 (22.5) 46 (27.1) 0.53
 Post-op analgesic 47 (95.9) 166 (97.6) 0.67
 Post-op sepsis 11 (22.5) 46 (27.1) 0.53
 Post-op blood transfusion 47 (95.9) 166 (97.6) 0.67

BP, blood pressure; EBL, estimated blood loss.

*P-value less than 0.05.

Incidence of AKI

The incidences of AKI were 18.7% (n = 41) and 17.4% (n = 38) within 24 h and Day 7 post-op, respectively, while the cumulative AKI incidence at 1-week post-op was 22.5% (n = 49). The proportion of diagnosed AKI varied with the diagnostic criteria employed; the highest incidence (22.5%) was observed when either SCr or urine output–based criteria was used (Table 4). The severity of AKI using KDIGO grading among participants with AKI showed 32 (65.3%) in Stage I, 11 (22.4%) in Stage II and 8 (16.2%) in Stage III.

Table 4.

Incidence of AKI based on different KDIGO diagnostic criteria

KDIGO criteria for AKI diagnosis n (%) (total; N = 219)
Increased serum creatinine >26.7 µmol/L 28 (12.7)
SCr criteria >1.5-fold from baseline 36 (16.2)
Urine output criteria alone: urine volume <0.5 mL/kg/h for 6 h 11 (5.0)
Combination of both SCr and urine output–based criteria 21 (9.6)
Diagnosis based on either SCr or urine output–based criteria 49 (22.4)

Factors associated with AKI

On multivariate analysis, only pre-existing kidney dysfunction, pre-op sepsis, anaemia and duration of surgery >120 min independently predicted AKI at the end of the 1-week post-op period (Table 5).

Table 5.

Logistic regression analysis of factors predicting AKI

Risk factors Odds ratio 95% CI P-value
Female gender 0.83 0.3949–1.0574 0.71
Pre-op sepsis 2.67 1.1198–7.3341 0.03*
Pre-existing kidney dysfunction 3.86 1.8075–9.7942 0.01*
Pre-op anaemia 2.91 1.0829–5. 2254 0.02*
Duration of anaesthesia >120 min 1.03 0.7324–5.9186 0.12
Duration of surgery >120 min 1.75 1.3912–11.4267 0.04*
Emergency surgery 1.44 0.5269–3.9106 0.48
Need for blood intra-op blood transfusion 0.93 0.8594–4.1937 0.65

*P-value less than 0.05.

Outcome data

Of the 219 participants enrolled, 49 (22.5%) had AKI; at the end of 30 day, 33 (67.3%) and 16 (32.7%) of those with AKI had full and partial recovery of their kidney function, respectively. Six participants (12.2%) among those with AKI required and had haemodialysis. The crude mortality rates (30 days post-op) among those with AKI and those without AKI were 10 (20.4%) and 9 (5.3%), respectively (P < 0.01).

Discussion

The incidence of AKI (22.5%) in our study was higher than the 1.9% reported among hospitalized adult patients by Adu et al. [7]. Our finding was similar to the 17.2% reported by Evans et al. [8] and 16.7% by Bagasha et al. [24] among adult hospitalized patients in a Ugandan and a Malawian hospital, respectively. Also, the AKI incidence in our study agreed with the 16.3% reported by Skinner et al. [25] among South African patients admitted with trauma. Of note is that the case mix of sepsis and trauma differs from ours because of specialty bias. The low incidence of AKI reported by Adu et al. [7] in their review is probably due to underestimation of the true incidence of AKI in SSA, as the low incidence might have resulted from the non-uniformity of definition of AKI across the studies included in their review. Supporting this explanation further is the similarity of the AKI incidence in our study to those reported by Evans et al. [8] and Skinner et al. [25] among patients who were admitted for medical- and trauma-related AKI, respectively. The general increase in the volume of surgical procedures may have also contributed to the increasing incidence of peri-op AKI in the SSA region, where mostly medical AKI had been previously reported [7, 9, 26].

The incidence of AKI in our study is similar to the pattern observed from the HICs among patients who underwent surgical interventions [27–30]. Although the incidence of AKI in our study is similar to the reports from HICs, the spectrum of surgical procedures performed was different in our cohort. Simple mastectomies with axillary clearance, exploratory laparotomies and total thyroidectomies were the predominant surgical procedures, unlike in HICs where cardiopulmonary surgery was the leading surgical procedure causing peri-op AKI [29–32].

Most of the identified AKI risk factors were modifiable and therefore preventive strategies for their early identification and prompt treatment should be part of the protocol for managing patients undergoing major surgical interventions to reduce the burden of AKI in this group of patients. Pre-op anaemia was observed to be associated with an increased risk of peri-op AKI by 3-fold. This is in agreement with the observations by Karkouti et al. [33] and De Santo et al. [34], who also reported anaemia as a predictor of peri-op AKI among patients who had cardiac surgery and coronary artery bypass graft, respectively. Optimizing the haemoglobin concentration prior to and during surgery has the potential of reducing the incidence of peri-op AKI and this can be achieved through pre-op blood transfusion in emergency settings or during surgery and using erythropoiesis stimulating agents in elective cases. Intra-op blood transfusion is a common occurrence in SSA, particularly in emergency surgical procedures [35–36]; not surprisingly, a quarter of our cohort required intra-op blood transfusions while 12.8% required further post-op blood transfusions.

Another factor that was associated with AKI in our study was sepsis. Sepsis causes AKI through multipronged injury pathways that include ischaemia–reperfusion injury, direct inflammatory injury, coagulation and endothelial cell dysfunction and apoptosis [37, 38]. Prompt treatment of severe sepsis prior to surgery using the international guideline for management of sepsis (Surviving Sepsis Campaign Guideline) is recommended [39]. This aggressive treatment of sepsis prior to surgical procedures is a cost-effective way of preventing peri-op AKI and its attendant outcomes, most especially in emergency cases, which are at higher risk of developing sepsis.

For surgery lasting >120 min, adequate fluid balance both prior to and during surgery must be ensured, in addition to optimal BP control to prevent episodes of intra-op hypotension and hypertension. These steps will reduce the risk of AKI in patients undergoing major surgery.

Pre-existing kidney dysfunction was identified as a predictor of AKI among our patients, although we couldn’t establish whether the pre-existing kidney dysfunction was chronic kidney disease (CKD) or AKI. This is because most of the participants had no baseline urinalysis and SCr records that were at least 3 months prior to admission for the surgical procedures. The existence of pre-existing kidney dysfunction in our study increased the risk of developing peri-op AKI by 4-fold. This finding is in keeping with previous reports that classified CKD as a risk factor for AKI [40]. Although CKD may not be reversible, prompt identification of modifiable peri-op risk factors for AKI and instituting preventive measures may safeguard against development of AKI, which is a known risk factor for CKD progression. Also, early involvement of nephrologists in the optimal care of at-risk patients prior to surgery will go a long way in reducing the burden of AKI among individuals undergoing surgical interventions.

This study is not without limitations, and these include the definition of pre-existing kidney dysfunction as eGFR <60 mL/min/1.73 m2, given that eGFR is not accurate when the kidney function is near normal. Second, due to limited funds, SCr was only measured pre-op, 24 h post-op, 7 days post-op and weekly until patients were discharged and thus some cases of AKI may have been missed. SCr as a marker of AKI has been shown to lag injury to the kidney, but the high cost of using early markers of AKI was prohibitive. Also, diabetes mellitus was based on self-reported history and/or the use of antidiabetic medications, as no plasma glucose was measured.

Conclusion

This study showed a high incidence of peri-op risk factors for AKI among patients undergoing major surgical procedures in a tertiary hospital in SSA. The cumulative incidence of AKI was high and independently associated with pre-op sepsis, anaemia, pre-existing kidney dysfunction and duration of surgery >120 min. The presence of AKI increased the mortality rate among individuals undergoing major surgical interventions. Prompt identification and aggressive treatment of peri-op AKI risk factors offer the potential of reducing the burden of AKI in this group of patients.

Acknowledgements

The authors acknowledge Sakiru Najeem, our research assistant, who worked assiduously to recruit participants for the study.

Funding

This work was funded by the International Society of Nephrology—Clinical Research and Prevention Program Proposal 04-057.

Conflict of interest statement

All authors report grants from the International Society of Nephrology during the conduct of the study.

References

  • 1. Rewa O, Bagshaw SM.. Acute kidney injury—epidemiology, outcomes and economics. Nat Rev Nephrol 2014; 10: 193–207 [DOI] [PubMed] [Google Scholar]
  • 2. Waikar SS, Liu KD, Chertow GM.. The incidence and prognostic significance of acute kidney injury. Curr Opin Nephrol Hypertens 2007; 16: 227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Susantitaphong P, Cruz DN, Cerda J. et al. World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol 2013; 8: 1482–1493 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Lameire NH, Bagga A, Cruz D. et al. Acute kidney injury: an increasing global concern. Lancet 2013; 382: 170–179 [DOI] [PubMed] [Google Scholar]
  • 5. Cerdá J, Lameire N, Eggers P. et al. Epidemiology of acute kidney injury. Clin J Am Soc Nephrol 2008; 3: 881–886 [DOI] [PubMed] [Google Scholar]
  • 6. Contini S. Surgery in developing countries: why and how to meet surgical needs worldwide. Acta Bio med 2007; 78: 4–5 [PubMed] [Google Scholar]
  • 7. Adu D, Okyere P, Boima V. et al. Community-acquired acute kidney injury in adults in Africa. Clin Nephrol 2016; 86: 48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Evans RD, Hemmilä U, Craik A. et al. Incidence, aetiology and outcome of community-acquired acute kidney injury in medical admissions in Malawi. BMC Nephrol 2017; 18: 21–28 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Olowu WA, Niang A, Osafo C. et al. Outcomes of acute kidney injury in children and adults in sub-Saharan Africa: a systematic review. Lancet Glob Health 2016; 4: e242–e250 [DOI] [PubMed] [Google Scholar]
  • 10. Luboga S, Macfarlane SB, Von Schreeb J. et al. Increasing access to surgical services in sub-saharan Africa: priorities for national and international agencies recommended by the Bellagio Essential Surgery Group. PLoS Med 2009; 6: e1000200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Lewington AJ, Cerdá J, Mehta RL.. Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney Int 2013; 84: 457–467 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Chhor V, Journois D.. Perioperative acute kidney injury and failure. Nephrol Ther 2014; 10: 121–131 [DOI] [PubMed] [Google Scholar]
  • 13. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012; 120: c179–c184 [DOI] [PubMed] [Google Scholar]
  • 14. Levey AS, Eckardt KU, Tsukamoto Y. et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089–2100 [DOI] [PubMed] [Google Scholar]
  • 15. World Health Organization. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. Geneva: World Health Organization, 2011. www.who.int/vmnis/indicators/haemoglobin.pdf (June 2017, date last accessed) [Google Scholar]
  • 16. Matot I, Sprung CL.. Definition of sepsis. Intensive Care Med 2001; 27: S3–S9 [DOI] [PubMed] [Google Scholar]
  • 17. Bone RC, Balk RA, Cerra FB. et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. Am Coll Chest Phys/Soc Crit Care Med Chest 1992; 101: 1644–1655 [DOI] [PubMed] [Google Scholar]
  • 18.WHO/ISH Hypertension Guidelines. www.who.int (June 2017, date last accessed)
  • 19.WHO Guideline on Prevention, Detection and Treatment of Diabetes Mellitus. www.who.int (June 2017, date last accessed)
  • 20. Charlson ME, MacKenzie CR, Gold JP. et al. Intraoperative blood pressure. What patterns identify patients at risk for postoperative complications? Ann Surg 1990; 212: 567–580 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Bijker JB, van Klei WA, Kappen TH. et al. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. J Am Soc Anesthesiol 2007; 107: 213–220 [DOI] [PubMed] [Google Scholar]
  • 22. Chawla LS, Bellomo R, Bihorac A. et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol 2017; 13: 241–257 [DOI] [PubMed] [Google Scholar]
  • 23. Huang YC, Huang SJ, Tsauo JY. et al. Definition, risk factors and outcome of prolonged surgical intensive care unit stay. Anaesth Intensive Care 2010; 38: 500–505 [DOI] [PubMed] [Google Scholar]
  • 24. Bagasha P, Nakwagala F, Kwizera A. et al. Acute kidney injury among adult patients with sepsis in a low-income country: clinical patterns and short-term outcomes. BMC Nephrol 2015; 16: 4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Skinner DL, Hardcastle TC, Rodseth RN. et al. The incidence and outcomes of acute kidney injury amongst patients admitted to a level I trauma unit. Injury 2014; 45: 259–264 [DOI] [PubMed] [Google Scholar]
  • 26. Hsia RY, Mbembati NA, Macfarlane S. et al. Access to emergency and surgical care in sub-Saharan Africa: the infrastructure gap. Health Policy Plan 2012; 27: 234–244 [DOI] [PubMed] [Google Scholar]
  • 27. Lenihan CR, Montez-Rath ME, Mangano CTM. et al. Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008. Ann Thorac Surg 2013; 95: 20–28 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Mangos GJ, Horton D, Brown MA. et al. Acute renal failure following cardiac surgery: incidence, outcomes and risk factors. Aust N Z J Med 1995; 25: 284–289 [DOI] [PubMed] [Google Scholar]
  • 29. Ishikawa S, Griesdale DE, Lohser J.. Acute kidney injury after lung resection surgery: incidence and perioperative risk factors. Anesth Analg 2012; 114: 1256–1262 [DOI] [PubMed] [Google Scholar]
  • 30. Rocha PN, Rocha AT, Palmer SM. et al. Acute renal failure after lung transplantation: incidence, predictors and impact on perioperative morbidity and mortality. Am J Transplant 2005; 5: 1469–1476 [DOI] [PubMed] [Google Scholar]
  • 31. Parolari A, Pesce LL, Pacini D. et al. Risk factors for perioperative acute kidney injury after adult cardiac surgery: role of perioperative management. Ann Thorac Surg 2012; 93: 584–591 [DOI] [PubMed] [Google Scholar]
  • 32. Borthwick E, Ferguson A.. Perioperative acute kidney injury: risk factors, recognition, management, and outcomes. BMJ 2010; 341: c3365. [DOI] [PubMed] [Google Scholar]
  • 33. Karkouti K, Wijeysundera DN, Yau TM. et al. Acute kidney injury after cardiac surgery. Circulation 2009; 119: 495–502 [DOI] [PubMed] [Google Scholar]
  • 34. De Santo L, Romano G, Della Corte A. et al. Preoperative anemia in patients undergoing coronary artery bypass grafting predicts acute kidney injury. J Thorac Cardiovasc Surg 2009; 138: 965–970 [DOI] [PubMed] [Google Scholar]
  • 35. Jani P, Howard A.. Blood transfusion in surgery in Africa. East Cent Afr J Surg 2011; 16: 7–19 [Google Scholar]
  • 36. Aderinto J, Brenkel IJ.. Pre-operative predictors of the requirement for blood transfusion following total hip replacement. J Bone Joint Surg Br 2004; 86: 970–973 [DOI] [PubMed] [Google Scholar]
  • 37. Pelte CH, Chawla LS.. Novel therapeutic targets for prevention and therapy of sepsis associated acute kidney injury. Curr Drug Targets 2009; 10: 1205–1211 [DOI] [PubMed] [Google Scholar]
  • 38. Bartels K, Karhausen J, Clambey ET. et al. Perioperative organ injury. J Am Soc Anesthesiol 2013; 119: 1474–1489 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Dellinger RP, Levy MM, Rhodes A. et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39: 165–228 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Singh P, Rifkin DE, Blantz RC.. Chronic kidney disease: an inherent risk factor for acute kidney injury? Clin J Am Soc Nephrol 2010; 5: 1690–1695 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Kidney Journal are provided here courtesy of Oxford University Press

RESOURCES